Man Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $343M | Sell |
5,658,497
-2,659,041
| -32% | -$155M | 0.62% | 18 |
|
|
2025
Q4 | $449M | Sell |
8,317,538
-910,622
| -10% | -$43.8M | 0.76% | 10 |
|
|
2025
Q3 | $416M | Buy |
9,228,160
+1,762,315
| +24% | +$82.3M | 0.72% | 11 |
|
|
2025
Q2 | $346M | Buy |
7,465,845
+5,503,391
| +280% | +$270M | 0.66% | 15 |
|
|
2025
Q1 | $120M | Buy |
1,962,454
+234,327
| +14% | +$13.7M | 0.3% | 66 |
|
|
2024
Q4 | $97.7M | Sell |
1,728,127
-1,501,885
| -46% | -$83.9M | 0.26% | 75 |
|
|
2024
Q3 | $167M | Sell |
3,230,012
-1,458,886
| -31% | -$68.4M | 0.44% | 29 |
|
|
2024
Q2 | $195M | Buy |
4,688,898
+2,862,266
| +157% | +$128M | 0.49% | 28 |
|
|
2024
Q1 | $99.1M | Sell |
1,826,632
-367,843
| -17% | -$18.7M | 0.25% | 85 |
|
|
2023
Q4 | $113M | Buy |
+2,194,475
| New | +$115M | 0.31% | 55 |
|
|
2023
Q3 | – | Sell |
-518,872
| Closed | -$31.8M | – | 471 |
|
|
2023
Q2 | $33.2M | Buy |
+518,872
| New | +$34.8M | 0.1% | 237 |
|
|
2023
Q1 | – | Sell |
-815,965
| Closed | -$57.6M | – | 218 |
|
|
2022
Q4 | $58.7M | Buy |
815,965
+205,055
| +34% | +$15.5M | 0.21% | 104 |
|
|
2022
Q3 | $43.4M | Buy |
+610,910
| New | +$44.3M | 0.2% | 118 |
|
|
2022
Q2 | – | Sell |
-219,882
| Closed | -$16.7M | – | 237 |
|
|
2022
Q1 | $16.1M | Sell |
219,882
-449,357
| -67% | -$30.2M | 0.06% | 403 |
|
|
2021
Q4 | $41.7M | Sell |
669,239
-601,842
| -47% | -$35.3M | 0.13% | 171 |
|
|
2021
Q3 | $75.2M | Buy |
1,271,081
+437,622
| +53% | +$28.8M | 0.26% | 78 |
|
|
2021
Q2 | $55.7M | Sell |
833,459
-1,109,122
| -57% | -$72.3M | 0.2% | 112 |
|
|
2021
Q1 | $123M | Sell |
1,942,581
-1,425,757
| -42% | -$88.7M | 0.54% | 23 |
|
|
2020
Q4 | $209M | Sell |
3,368,338
-779,926
| -19% | -$48M | 0.92% | 14 |
|
|
2020
Q3 | $250M | Buy |
4,148,264
+583,812
| +16% | +$35.1M | 0.98% | 10 |
|
|
2020
Q2 | $210M | Buy |
3,564,452
+2,427,666
| +214% | +$145M | 1.06% | 10 |
|
|
2020
Q1 | $63.4M | Sell |
1,136,786
-944,052
| -45% | -$57.7M | 0.41% | 50 |
|
|
2019
Q4 | $134M | Buy |
2,080,838
+1,591,579
| +325% | +$91.2M | 0.44% | 39 |
|
|
2019
Q3 | $24.8M | Sell |
489,259
-1,366,433
| -74% | -$64.2M | 0.09% | 265 |
|
|
2019
Q2 | $84.2M | Sell |
1,855,692
-965,384
| -34% | -$45M | 0.3% | 54 |
|
|
2019
Q1 | $135M | Sell |
2,821,076
-782,118
| -22% | -$39M | 0.51% | 24 |
|
|
2018
Q4 | $187M | Buy |
3,603,194
+1,786,780
| +98% | +$96M | 0.83% | 16 |
|
|
2018
Q3 | $113M | Buy |
1,816,414
+737,891
| +68% | +$43.8M | 0.41% | 39 |
|
|
2018
Q2 | $59.7M | Buy |
1,078,523
+797,899
| +284% | +$43.1M | 0.25% | 66 |
|
|
2018
Q1 | $17.8M | Buy |
+280,624
| New | +$18.1M | 0.08% | 273 |
|
Other funds holding BMY
VCM
VPM
Man Group's BMY Position: Q1 2026 in Review
Man Group reduced its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, selling an estimated $155M and leaving 5,658,497 shares worth $343M. The position accounts for 0.62% of the portfolio, ranked #18.
Man Group first reported a position in BMY in Q1 2018 and has held it in 30 quarters since. The position peaked at $449M in Q4 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Man Group held 5,658,497 shares of Bristol-Myers Squibb worth $343M as of Q1 2026.
- Man Group sold 2,659,041 Bristol-Myers Squibb shares in Q1 2026, an estimated $155M.
- Bristol-Myers Squibb made up 0.62% of Man Group's portfolio in Q1 2026, its #18 holding.
- Man Group first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 30 quarters since.
- Man Group's Bristol-Myers Squibb position peaked at $449M in Q4 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.